69 related articles for article (PubMed ID: 9102151)
1. [Alzheimer's disease lesions: from morphology to cell biology].
Hauw JJ; Seilhean D; Piette F; Uchihara T; Duyckaerts C
Bull Acad Natl Med; 1996 Oct; 180(7):1687-700; discussion 1700-1. PubMed ID: 9102151
[TBL] [Abstract][Full Text] [Related]
2. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
5. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol and pathological processes in Alzheimer's disease.
Yanagisawa K
J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
[TBL] [Abstract][Full Text] [Related]
8. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
9. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease].
Dessi F; Colle MA; Hauw JJ; Duyckaerts C
Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
11. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
12. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
Gómez-Ramos P; Mufson EJ; Morán MA
Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
16. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
18. Variations in the neuropathology of familial Alzheimer's disease.
Shepherd C; McCann H; Halliday GM
Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of Alzheimer's disease].
Alegre M; Noé E; Luquin MR
Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
[TBL] [Abstract][Full Text] [Related]
20. Identification of a unique apolipoprotein E allele in Microcebus murinus; ApoE brain distribution and co-localization with beta-amyloid and tau proteins.
Calenda A; Jallageas V; Silhol S; Bellis M; Bons N
Neurobiol Dis; 1995 Jun; 2(3):169-76. PubMed ID: 9174000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
